Mardi Dier insider trades
Open-market stock purchases and sales by Mardi Dier, EVP and CFO at Madrigal Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 6, 2013.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -85%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $34.9K |
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $17.5K |
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $179K |
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $50.2K |
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $69.5K |
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $279K |
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $51.7K |
| Mar 4, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 4, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 2, 2026 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $505K |
| Jan 2, 2026 | ORIC Oric Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $149K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $278K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $141K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $44K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $47.7K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $235K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $203K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $412K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $69K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $185K |
| Dec 2, 2025 | MDGL Madrigal Pharmaceuticals, Inc | Sold | $94.5K |
Companies traded
- MDGL Madrigal Pharmaceuticals, Inc: 22 sales, last Mar 6, 2026
- ORIC Oric Pharmaceuticals, Inc: other filings, last Jan 2, 2026
- PRLD Prelude Therapeutics Inc: 1 buy, last Jun 12, 2025
- SLRN ACELYRIN, Inc: 2 buys, last May 9, 2023
- RARE Ultragenyx Pharmaceutical Inc: 6 sales, last Oct 14, 2022
- ADMS Adamas Pharmaceuticals Inc: other filings, last Jun 2, 2021
- PTLA Portola Pharmaceuticals Inc: 22 sales, last Jul 2, 2020